CN Patent

CN102485724B — 取代噻吩基吡唑并吡啶类化合物及其医药用途

Assigned to Institute of Pharmacology and Toxicology of AMMS · Expires 2015-08-12 · 11y expired

What this patent protects

本发明涉及新型取代噻吩基吡唑并吡啶类化合物及其医药用途。具体地说，本发明涉及式I化合物，及其异构体药学可接受的盐、溶剂合物：其中各取代基的定义如说明书所述。本发明还涉及包含所述化合物的药物组合物、以及所述化合物在制备用于治疗和/或预防与心血管有关的疾病或病症的药物中的用途。本发明式I化合物可以有益地治疗和/或预防与心血管有关的疾病或病症。

USPTO Abstract

本发明涉及新型取代噻吩基吡唑并吡啶类化合物及其医药用途。具体地说，本发明涉及式I化合物，及其异构体药学可接受的盐、溶剂合物：其中各取代基的定义如说明书所述。本发明还涉及包含所述化合物的药物组合物、以及所述化合物在制备用于治疗和/或预防与心血管有关的疾病或病症的药物中的用途。本发明式I化合物可以有益地治疗和/或预防与心血管有关的疾病或病症。

Drugs covered by this patent

Patent Metadata

Patent number
CN102485724B
Jurisdiction
CN
Classification
—
Expires
2015-08-12
Drug substance claim
No
Drug product claim
No
Assignee
Institute of Pharmacology and Toxicology of AMMS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.